Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Recce Pharmaceuticals Ltd. ( (AU:RCE) ) has shared an announcement.
Recce Pharmaceuticals Ltd announced a proposed issue of securities, with a total of 38,645,269 ordinary fully paid securities to be issued through a standard pro rata issue and an additional 17,857,143 securities through a placement. This move is likely aimed at raising capital to support the company’s operations and strategic initiatives, potentially enhancing its market position and providing opportunities for stakeholders.
More about Recce Pharmaceuticals Ltd.
Recce Pharmaceuticals Ltd is a company operating in the pharmaceutical industry, focusing on the development and commercialization of novel antibiotics. The company is known for its innovative approach to addressing antibiotic resistance, a significant concern in the healthcare sector.
YTD Price Performance: -28.12%
Average Trading Volume: 184,492
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$76.52M
Learn more about RCE stock on TipRanks’ Stock Analysis page.